mass-spectroscopy based, high-throughput massarray iplextm platform (Sequenom)
90
Structured Review
Sequenom
mass-spectroscopy based, high-throughput massarray iplextm platform
Mass Spectroscopy Based, High Throughput Massarray Iplextm Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectroscopy-based%2C+high-throughput+massarray+iplextm+platform/sequenom+massarray/pm23312054-45-20-26
Average 90 stars, based on 1 article reviews
Mass Spectroscopy Based, High Throughput Massarray Iplextm Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectroscopy-based%2C+high-throughput+massarray+iplextm+platform/sequenom+massarray/pm23312054-45-20-26
Average 90 stars, based on 1 article reviews
mass-spectroscopy based, high-throughput massarray iplextm platform - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Gender-dependent associations of uric acid levels with a polymorphism in SLC2A9 in Han Chinese patients. Article Snippet: Hyperuricaemia predisposes to gout and is associated with increased risk of cardiovascular disease probably through a relationship with other cardiovascular risk factors, including metabolic syndrome, hypertension, and renal disease (1), and possibly through an independent effect (2).. Several new loci have been identified to be associated with serum uric acid levels and gout in recent genome-wide association studies (GWAS), with the strongest signals detected for the solute carrier family 2, member 9 gene (SLC2A9) variants in various populations (3–5).. The present study examined associations of eight single nucleotide polymorphisms (SNPs) in five of the most relevant candidate genes with uric acid levels in Chinese patients with increased cardiovascular risk requiring statin therapy. |